Luminescence-based imaging-fiber oxygen sensors (IFOSs) were utilized for t
he in situ measurement of oxygen consumption from intact perfused mouse hea
rts. IFOSs were fabricated using a technically expedient, photoinitiated po
lymerization reaction whereby an oxygen-sensitive polymer matrix was immobi
lized in a precise location on an imaging fiber's distal face. The oxygen-s
ensing layer used in this work comprised a transition metal complex, Ru(Ph(
2)phen)(3)(2+), entrapped in a gas-permeable photopolymerizable siloxane me
mbrane (PS802). The transduction mechanism was based upon the oxygen collis
ional quenching of the ruthenium complex luminescence; detection was perfor
med utilizing an epi-fluorescence microscope/charge coupled device imaging
system. IFOS measurements from working mouse hearts were validated through
concurrent, blind, ex situ blood gas analyzer (BGA) measurements, The EGA a
nd IFOS methodologies were utilized successfully to measure oxygen concentr
ations in aortic and pulmonary artery perfusates from the working mouse hea
rt before and after isoproterenol administration. Coupled with coronary-flo
w measurements, these data were used to calculate myocardial oxygen consump
tion. Regression analysis of measurements of myocardial oxygen consumption
showed that there was a strong correlation between the values generated by
the EGA sampling and those obtained via in situ IFOS methods. To our knowle
dge, this research represents the first report of in situ fiber-optic senso
r monitoring of oxygen content from the intact, beating mouse heart.